Minerva Neurosciences, Inc.NERVNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank21
3Y CAGR-15.7%
5Y CAGR-17.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-15.7%/yr
vs -16.4%/yr prior
5Y CAGR
-17.4%/yr
Consistent
Acceleration
+0.7pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.10M | -30.9% |
| 2024 | $21.85M | -5.5% |
| 2023 | $23.12M | -8.4% |
| 2022 | $25.23M | -44.4% |
| 2021 | $45.37M | +15.3% |
| 2020 | $39.33M | -48.2% |
| 2019 | $75.86M | +46.7% |
| 2018 | $51.73M | +25.6% |
| 2017 | $41.17M | +36.4% |
| 2016 | $30.19M | - |